Related Experiment Video
Updated: Aug 8, 2026
07:13
A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
[Changes in hypertrophy and diastolic left ventricular function during hypertension therapy]
L Elbl1, V Chaloupka, R Soucek
1Oddĕlení funkcního vysetrování FNsP, Brno.
Vnitrni Lekarstvi
|June 1, 1992
Summary
Treatment normalized blood pressure in patients with primary hypertension and left ventricular hypertrophy (LVH). However, significant regression of LVH was not observed, indicating limited impact on cardiac remodeling despite controlled hypertension.
Area of Science:
- Cardiology
- Hypertension Research
- Echocardiography
Context:
- Primary hypertension often coexists with left ventricular hypertrophy (LVH).
- Understanding treatment effects on cardiac structure and function is crucial.
Purpose:
- To investigate the impact of antihypertensive treatment on left ventricular morphology and function in patients with primary hypertension and LVH.
- To assess the relationship between blood pressure control and cardiac remodeling.
Summary:
- Long-term normalization of blood pressure did not lead to significant regression of LVH.
- No consistent relationship was found between casual blood pressure and left ventricular weight, except for post-load diastolic pressure.
- Diastolic function indicators correlated with end-diastolic volume and blood pressure changes, not LV weight.
Impact:
- Current antihypertensive strategies may not fully reverse established LVH.
- Further research is needed to identify effective treatments for LVH regression in hypertensive patients.
- Highlights the complex interplay between blood pressure, cardiac structure, and diastolic function.
More Related Videos
Related Concept Videos
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...